122
Views
1
CrossRef citations to date
0
Altmetric
Case Reports

Lurking below: massive choroidal invasion under a calcified tumor after attempted conservative therapy for retinoblastoma

, , , &
Pages 653-657 | Received 23 May 2018, Accepted 05 Aug 2018, Published online: 24 Aug 2018

References

  • Shields CL, Mashayekhi A, Cater J, Shelil A, Meadows AT, Shields JA. Chemoreduction for retinoblastoma. Analysis of tumor control and risks for recurrence in 457 tumors. Am J Ophthalmol. 2004;138(3):329–37. doi:10.1016/j.ajo.2004.04.032.
  • Messmer EP, Heinrich T, Hopping W, De Sutter E, Havers W, Sauerwein W. Risk factors for metastases in patients with retinoblastoma. Ophthalmology. 1991;98(2):136–41.
  • Berry JL, Kogachi K, Aziz HA, McGovern K, Zolfaghari E, Murphree AL, Jubran R, Kim JW. Risk of metastasis and orbital recurrence in advanced retinoblastoma eyes treated with systemic chemoreduction versus primary enucleation. Pediatr Blood Cancer. 2017;64(4). doi:10.1002/pbc.26270.
  • Berry JL, Jubran R, Lee TC, Murphree AL, Lee D, Kim JW. Low-dose chemoreduction for infants diagnosed with retinoblastoma before 6 months of age. Ocul Oncol Pathol. 2015;1(2):103–10. doi:10.1159/000370215.
  • Tateishi U, Hasegawa T, Miyakawa K, Sumi M, Moriyama N. CT and MRI features of recurrent tumors and second primary neoplasms in pediatric patients with retinoblastoma. AJR Am J Roentgenol. 2003;181(3):879–84. doi:10.2214/ajr.181.3.1810879.
  • Char DH, Hedges TR 3rd, Norman D. Retinoblastoma. CT diagnosis. Ophthalmology. 1984;91(11):1347–50.
  • Lemke AJ, Kazi I, Mergner U, Foerster PI, Heimann H, Bechrakis N, Schuler A, von Pilsach MI, Foerster M, Felix R, et al. Retinoblastoma – MR appearance using a surface coil in comparison with histopathological results. Eur Radiol. 2007;17(1):49–60. doi:10.1007/s00330-006-0197-2.
  • Sang DN, Albert DM. Retinoblastoma: clinical and histopathologic features. Hum Pathol. 1982;13(2):133–47.
  • Lin CC, Tso MO. An electron microscopic study of calcification of retinoblastoma. Am J Ophthalmol. 1983;96(6):765–74.
  • Benhamou E, Borges J, Tso MO. Magnetic resonance imaging in retinoblastoma and retinocytoma: a case report. J Pediatr Ophthalmol Strabismus. 1989;26(6):276–80.
  • Rootman DB, Gonzalez E, Mallipatna A, Vandenhoven C, Hampton L, Dimaras H, Chan HS, Gallie BL, Heon E. Hand-held high-resolution spectral domain optical coherence tomography in retinoblastoma: clinical and morphologic considerations. Br J Ophthalmol. 2013;97(1):59–65. doi:10.1136/bjophthalmol-2012-302133.
  • Seider MI, Grewal DS, Mruthyunjaya P. Portable optical coherence tomography detection or confirmation of ophthalmoscopically invisible or indeterminate active retinoblastoma. Ophthalmic Surg Lasers Imaging Retina. 2016;47(10):965–68. doi:10.3928/23258160-20161004-12.
  • Park K, Sioufi K, Shields CL. Clinically invisible retinoblastoma recurrence in an infant. Retin Cases Brief Rep. 2017. doi:10.1097/ICB.0000000000000555.
  • Gonzalez-Montpetit ME, Samara WA, Magrath GN, Shields CL. Detection of minimally visible recurrent retinoblastoma by hand-held spectral-domain optical coherence tomography. J Pediatr Ophthalmol Strabismus. 2017;54:e6–e8. doi:10.3928/01913913-20170201-03.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.